lysosome

Type: Keyphrase
Name: lysosome
First reported 19 hours ago - Updated 1 hour ago - 1 reports

MLDA Hopes To Raise RM20 Million For LSD Patients

KUALA LUMPUR, Sept 1 (Bernama) -- The Malaysia Lysosomal Diseases Association (MLDA) hopes to raise RM20 million for a fund to provide Lysosomal Storage Disease (LSD) patients sufficient treatment.Its president, Lee Yee Seng said the association now ... [Published Bernama - 19 hours ago]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

BioMarin Pharmaceutical Crosses Above it...

Today, shares of BioMarin Pharmaceutical (NASDAQ:BMRN) have crossed bullishly above their 10-day moving average of $70.17 on a volume of 265K shares. Swing traders may find an opportunity for a long position, as such a crossover often suggests higher ... [Published Financial News Network online - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

FDA puts Pfizer superbug vaccine on fast track

The US Food and Drug Administration has agreed to undertake a speedy review of an experimental Clostridium difficile vaccine being developed by Pfizer.The jab, which is currently dubbed PF-06425090, is being tested in Phase II trials for preventing illness ... [Published Pharma Times - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Altered Surfactant Homeostasis And Alveolar Epithelial Cell Stress In Amiodarone Induced Lung Fibrosis

AbstractAmiodarone (AD) is a highly efficient antiarrhythmic drug with potentially serious side effects. Severe pulmonary toxicity is reported in patients receiving AD even at low doses, and may cause interstitial pneumonia as well as lung fibrosis. Apoptosis ... [Published Toxicological Sciences - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 28 2014 - 1 reports

Reports from National Institute of Environmental Research Highlight Recent Findings in Myeloid Cells (Magnetite- and maghemite-induced different...

Reports from National Institute of Environmental Research Highlight Recent Findings in Myeloid Cells (Magnetite- and maghemite-induced different toxicity in murine alveolar macrophage cells)By a News Reporter-Staff News Editor at Health & Medicine Week ... [Published HispanicBusiness.com - Aug 27 2014]
Entities: myeloid, Murine, macrophage
First reported Aug 26 2014 - Updated Aug 27 2014 - 2 reports

Attacking a rare disease at its source with gene therapy

PHILADELPHIA Treating the rare disease MPS I is a challenge. MPS I, caused by the deficiency of a key enzyme called IDUA, eventually leads to the abnormal accumulation of certain molecules and cell death.The two main treatments for MPS I are bone marrow ... [Published Bio-Medicine - Aug 26 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Five of the Most Promising Drugs Entering Phase III Trials

Ben Turner takes a look at five of the most promising drugs to watch that are entering phase III trials at the moment. The first drug moving into phase III is targeted at the treatment of Pompe disease, a lysosomal storage disorder caused by an inherited ... [Published BioPortfolio - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Lysosomal storage disorders are a particularly lucrative corner of ultra-orphan market

A new report by Thomson Reuters has highlighted the economic power of ultra-orphan diseases, the informal category for those illnesses that affect fewer than 10,000 people.It particularly focuses on the potential of lysosomal storage disorders as ultra-orphan ... [Published Pharma Letter - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Cellular Garbage Contributes to Neurodegenerative Diseases

Several human neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's Diseases, are linked to an accumulation of abnormal and aggregated proteins in cells. Cellular 'garbage' can be removed from cells by sweeping them to a cellular ... [Published World Health Network - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

TPC interactome [Cell Biology]

Yaping Lin-Moshier a , Michael V. Keebler a , Robert Hooper b , Michael J. Boulware a , Xiaolong Liu a , Dev Churamani b , Mary E. Abood c , Timothy F. Walseth a , Eugen Brailoiu c , Sandip Patel b , and Jonathan S. Marchant a , 1 a Department ... [Published PNAS - Aug 26 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 2 reports

Research and Markets: Global Lysosomal Storage Diseases Market 2014-2018: Key Vendors are Actelion Pharmaceuticals, …

DUBLIN--(BUSINESS WIRE)--Research and Markets ( http://www.researchandmarkets.com/research/5f7fvn/global_lysosomal ) has announced the addition of the "Global Lysosomal Storage Diseases Market 2014-2018" report to their offering.The Global Lysosomal ... [Published Yahoo! Finance - Aug 21 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 2 reports

Studies from Singapore National University in the Area of Nanomaterials Described (The influence of lysosomal stability of silver nanomaterials on...

at 20:15 PM EDT Studies from Singapore National University in the Area of Nanomaterials Described (The influence of lysosomal stability of silver nanomaterials on their toxicity to human cells) By a News Reporter-Staff News Editor at Life Science Weekly ... [Published Industrial Info Financials - Aug 07 2014]

Quotes

"To date, MLDA has identified 44 patients with LSDs and 20 of them are on the waiting list to receive treatment because of insufficient funds. Each patient needs at least RM1 million per annum to undergo treatment" he said after taking part in the Ice Bucket Challenge (IBC) for LSDs, here, Monday
"The approval of Elelyso to treat paediatric patients with type 1 Gaucher disease provides physicians another treatment option for this rare and potentially debilitating disease,” said Rory O Connor, senior vice president, global medical affairs, Global Innovative Pharma Business, Pfizer Inc. “This paediatric indication, along with the recent announcement that Elelyso received kosher certification by the Orthodox Union (OU), reinforces the ongoing commitment of Pfizer to addressing the needs of the Gaucher community.”"
"FIG. 11 shows an in vivo differentiation (mouse subcutaneous) of the umbilical cord-derived stem cells according to Example 8 through various staining methods;"

More Content

All (240) | News (183) | Reports (0) | Blogs (53) | Audio/Video (1) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
TLR sorting by Rab11 endosomes maintains intest... [Published EMBO Journal - 12 hours ago]
MLDA Hopes To Raise RM20 Million For LSD Patients [Published Bernama - 19 hours ago]
US FDA approves Elelyso for injection for paedi... [Published PharmaBiz - Aug 30 2014]
Insider Selling: Jayne Gershkowitz Unloads 5,00... [Published American Banking News - Forex - Aug 30 2014]
Expression of Inducible Nitric Oxide Synthase (... [Published Plosone.org - Aug 30 2014]
Amicus Therapeutics Trading Down 3.2% After Ins... [Published American Banking News - Forex - Aug 30 2014]
BioMarin Pharmaceutical Crosses Above it... [Published Financial News Network online - Aug 29 2014]
FDA puts Pfizer superbug vaccine on fast track [Published Pharma Times - Aug 29 2014]
Altered Surfactant Homeostasis And Alveolar Epi... [Published Toxicological Sciences - Aug 28 2014]
Patent Application Titled "Cartilage Cell Treat... [Published 4 Traders - Aug 28 2014]
New Nucleic Acids Research Study Findings Have ... [Published 4 Traders - Aug 28 2014]
Reports from National Institute of Environmenta... [Published HispanicBusiness.com - Aug 27 2014]
Insider Selling: Amicus Therapeutics COO Sells ... [Published Mideast Time - Aug 27 2014]
Researchers at University of California Target ... [Published Pharmacy Choice - Aug 27 2014]
After a string of gene therapy licensing deals,... [Published FierceBiotech - Aug 27 2014]
Amicus Therapeutics VP Sells $30,000 in Stock (... [Published Mideast Time - Aug 27 2014]
Amicus Therapeutics VP Unloads $30,000 in Stock... [Published American Banking News - Aug 27 2014]
Amicus Therapeutics COO Sells 7,000 Shares (FOLD) [Published American Banking News - Aug 27 2014]
Five of the Most Promising Drugs Entering Phase... [Published BioPortfolio - Aug 27 2014]
Attacking a rare disease at its source with gen... [Published Bio-Medicine - Aug 26 2014]
Attacking a rare disease at its source with gen... [Published EurekAlert! - Aug 26 2014]
15.7% Return Seen to Date on SmarTrend BioMarin... [Published Comtex SmarTrend - Aug 26 2014]
Lysosomal storage disorders are a particularly ... [Published Pharma Letter - Aug 26 2014]
Cellular Garbage Contributes to Neurodegenerati... [Published World Health Network - Aug 26 2014]
TPC interactome [Cell Biology] [Published PNAS - Aug 26 2014]
In Silico Identification of New Putative Pathog... [Published Plosone.org - Aug 26 2014]
A Grandmother's Promise [Published Newswise - Aug 25 2014]
FDA approves U-M-invented drug for Gaucher disease [Published Health Canal - Aug 24 2014]
Karnataka govt yet to disburse Rs.10 cr for ded... [Published PharmaBiz - Aug 23 2014]
Ocular and Histologic Findings in a Series of C... [Published Orthopedics Today - Aug 22 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Global Lysosomal Storage Diseases Market 2014-2... [Published PR Newswire: General Business - Aug 18 2014]
DUBLIN, Aug. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Lysosomal Storage Diseases Market 2014-2018" report to their offering. The term lysosomal storage diseases refers to a group of rare inherited disorders ...
Working Towards a Way to Clear Cytomegalovirus [Published Fight Aging! - Aug 14 2014]
Like other herpesviruses , cytomegalovirus (CMV) cannot be effectively naturally cleared from the body as it has evolved the means to hide from the immune system . It is harmless for most people in the short term, but over the long term it causes ...
Lysosomal Storage Disorder-Pipeline Insights, 2014 [Published PR Newswire: Entertainment & Media - Aug 12 2014]
LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Lysosomal Storage Disorder-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278642/-Lysosomal-Storage-Disorder-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," ...
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Aug 05 2014]
Beta Cyclodextrins as a Possible Treatment for ... [Published Fight Aging! - Jul 15 2014]
Liposfucin is the name given to a mix of hardy metabolic waste compounds that build up in long-lived cells over the years, such as the vital cell populations of the retina . Cells are not equipped with suitable tools to remove this gunk, but they ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Magnetically treated nanoparticles help tumour ... [Published Reuters Video: Technology - Jul 07 2014]
1

Press Releases

sort by: Date | Relevance
Amicus Therapeutics Analyst Report; Solid Pipel... [Published Financial Services - Jul 07 2014]
BioMarin Doses First Patient in Phase 3 INSPIRE... [Published GlobeNewswire: Acquisitions News - May 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.